- Trial of Moxifloxacin-containing Triple Therapy after Initial and Second-line Treatment Failures for Helicobacter pylori Infection
-
Cheon JH, Kim N, Lee DH, Kim JW, Hwang JH, Park YS, Kim JM, Suh SO, Jung HC, Song IS
- KMID: 2439745
- Korean J Gastroenterol.
- 2005 Feb;45(2):111-117.
BACKGROUND/AIMS: Proton-pump inhibitor (PPI)-based triple therapy for Helicobacter pylori eradication is widely used with considerable failure rate. Bismuth-based, second-line therapy is also associated with failures in more than 20%... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of 14 Day OBMT Therapy as a Second-line Treatment for Helicobacter pylori Infection
-
Park SC, Chun HJ, Jung SW, Keum B, Han WS, Choung RS, Kim YS, Jeen YT, Lee HS, Um SH, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH
- KMID: 1113356
- Korean J Gastroenterol.
- 2004 Sep;44(3):136-141.
BACKGROUND/AIMS: As a second-line treatment for H. pylori eradication in the case of first-line OAC (omeprazole, amoxicillin, clarithromycin) treatment failure, a minimum of one-week OBMT quadruple therapy composed of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Trend of Eradication Rates of Second-Line Quadruple Therapy Containing Metronidazole for Helicobacter pylori Infection: An Analysis of Recent Eight Years
-
Lee JH, Cheon JH, Park MJ, Kim N, Lee DH, Kim JM, Kim JS, Jung HC, Song IS
- KMID: 1113429
- Korean J Gastroenterol.
- 2005 Aug;46(2):94-98.
BACKGROUND/AIMS: Failure rates of Helicobacter pylori eradication treatment turned out to be exceeding 10%, causing recurrence of peptic ulcers. In the case of eradication failure, the Korean College of... -
- CITED
-
- Close
- SHARE
-
- Close
